These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 12452033

  • 1. [Effect of soluble vascular endothelial growth factor (VEGF) receptor gene (sflt-1) and antisense VEGF nucleotide on neovascularization].
    Mi J, Wang JH, Chen SS.
    Ai Zheng; 2002 May; 21(5):464-8. PubMed ID: 12452033
    [Abstract] [Full Text] [Related]

  • 2. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S, Sakamoto T, Yoshikawa H, Hata Y, Kawano Y, Ishibashi T, Inomata H, Takayama K, Ueno H.
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [Abstract] [Full Text] [Related]

  • 3. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S, D'Souza SS, Gururaj AE, Shaila MS, Salimath BP.
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [Abstract] [Full Text] [Related]

  • 4. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
    Hasumi Y, Mizukami H, Urabe M, Kohno T, Takeuchi K, Kume A, Momoeda M, Yoshikawa H, Tsuruo T, Shibuya M, Taketani Y, Ozawa K.
    Cancer Res; 2002 Apr 01; 62(7):2019-23. PubMed ID: 11929819
    [Abstract] [Full Text] [Related]

  • 5. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Zhang Z, Zou W, Wang J, Gu J, Dang Y, Li B, Zhao L, Qian C, Qian Q, Liu X.
    Mol Ther; 2005 Apr 01; 11(4):553-62. PubMed ID: 15771958
    [Abstract] [Full Text] [Related]

  • 6. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
    Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A, Kovesdi I, Balestrazzi E, Abeni DC, Ali RR, Capogrossi MC.
    J Gene Med; 2004 Sep 01; 6(9):992-1002. PubMed ID: 15352072
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
    Mahasreshti PJ, Navarro JG, Kataram M, Wang MH, Carey D, Siegal GP, Barnes MN, Nettelbeck DM, Alvarez RD, Hemminki A, Curiel DT.
    Clin Cancer Res; 2001 Jul 01; 7(7):2057-66. PubMed ID: 11448924
    [Abstract] [Full Text] [Related]

  • 8. Expression of soluble Flt-1 gene in Pichia pastoris and the effect of the product on multiple-myeloma cells in vitro.
    Liu J, Li J, Su C, Huang B, Luo S.
    Biotechnol Appl Biochem; 2008 Feb 01; 49(Pt 2):97-104. PubMed ID: 17614789
    [Abstract] [Full Text] [Related]

  • 9. [Experimental study of human colon cell line Lovo transfected with soluble vascular endothelial growth factor receptor 1 gene].
    Zheng CX, Wu RY, Chen LH, Tan M.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul 01; 12(4):416-9. PubMed ID: 19598033
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
    Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Haisma HJ, Alvarez RD, Curiel DT.
    Clin Cancer Res; 2003 Jul 15; 9(7):2701-10. PubMed ID: 12855650
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.
    Oncogene; 2005 Jan 27; 24(5):790-800. PubMed ID: 15592523
    [Abstract] [Full Text] [Related]

  • 15. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y, Wang S, Hoot DR, Clinton SK.
    J Nutr Biochem; 2007 Jun 27; 18(6):408-17. PubMed ID: 17142033
    [Abstract] [Full Text] [Related]

  • 16. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells.
    Ohtani K, Egashira K, Hiasa K, Zhao Q, Kitamoto S, Ishibashi M, Usui M, Inoue S, Yonemitsu Y, Sueishi K, Sata M, Shibuya M, Sunagawa K.
    Circulation; 2004 Oct 19; 110(16):2444-52. PubMed ID: 15477409
    [Abstract] [Full Text] [Related]

  • 17. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1.
    Sivanandam VG, Stephen SL, Hernandez-Alcoceba R, Alzuguren P, Zabala M, van Rooijen N, Qian C, Berger I, Gross ML, Prieto J, Kochanek S.
    J Gene Med; 2008 Oct 19; 10(10):1083-91. PubMed ID: 18720430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
    Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE.
    Gene Ther; 2002 Jun 19; 9(12):804-13. PubMed ID: 12040462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.